ENTRY       D00584                      Drug
NAME        Fluorouracil (JP17/USP/INN);
            5-FU (TN);
            Adrucil (TN);
            Carac (TN);
            Fluoroplex (TN)
PRODUCT     FLUOROPLEX (Aqua Pharmaceuticals) 258bb79a-56b3-4f46-ade6-7331ec031074
            TOLAK (HILL DERMACEUTICALS) 59de2709-00b8-4f0a-867c-f0dfeb947192
            FLUOROURACIL (Mylan Pharmaceuticals) 744737c5-0d96-4214-82ab-6cff016b1ea0
            TOLAK (Pierre Fabre Pharmaceuticals) e37ae7a6-7074-4744-8d56-c85d7e4ad587
            FLUOROURACIL (Solco Healthcare US LLC) e4acd6ec-d981-4756-9c59-7ee981be9c12
            EFUDEX (Valeant Pharmaceuticals North America LLC) 35de1c1c-bef5-46c5-b6f8-ea032147411c
            CARAC (Valeant Pharmaceuticals North America LLC) 6795f2b1-1381-4a4f-ad34-2c28ebd1cfaf
  GENERIC   FLUOROURACIL (Accord Healthcare) 66d451fe-2436-494c-80c5-4528c8e34369
            FLUOROURACIL (Accord Healthcare) 8eff167f-203a-4a81-b2fc-d8773bc3555e
            FLUOROURACIL (BluePoint Laboratories) 513ca7e7-6867-4f15-b688-6469bb8c82de
            FLUOROURACIL (BluePoint Laboratories) d91670fd-7825-4fb9-afc7-a03a595fc70c
            FLUOROURACIL (Fresenius Kabi USA) 21af1777-87f7-4e40-9917-f1677e7ff1a5
            FLUOROURACIL (Fresenius Kabi USA) a85ab26a-05ea-498f-8f34-564a925fa9d9
            FLUOROURACIL (Fresenius Kabi USA) b4328ae3-f48f-40b1-9719-1c1aced7c734
            FLUOROURACIL (Fresenius Kabi USA) beb8c6c5-4b6e-4770-b6d4-718e33c7a2ff
            FLUOROURACIL (Fresenius Kabi USA) c45f5286-a52b-43e5-8a6f-d0312e7da0c8
            FLUOROURACIL (Fresenius Kabi USA) fdf2a165-2ca4-48be-89c1-570e6010b47c
            FLUOROURACIL (Pfizer Laboratories Div Pfizer) 64b6cb19-b6c0-4e02-9fae-39d5d61e15e4
            FLUOROURACIL (Pfizer Laboratories Div Pfizer) e301c810-0edc-4d21-8ccd-ec9653249019
            FLUOROURACIL (Physicians Total Care) bf851a7f-902d-4f1d-9d19-fd9cd5701fcd
            FLUOROURACIL (Rebel Distributors Corp) 4d8f6f8f-a69a-48db-8ee1-3b23989cb11f
            FLUOROURACIL (Sagent Pharmaceuticals) 37e35e8c-5d51-413b-a3a0-b72a18caaf65
            FLUOROURACIL (Sandoz) 1911e06a-2f16-4b99-adfa-4b914d559e1e
            FLUOROURACIL (Sandoz) 1b835751-d6a4-49b6-b0f8-23ab31b0d04e
            FLUOROURACIL (Spear Dermatology Products) 58fa81e2-9dbc-4cef-82d4-e5dc4aec5b26
            FLUOROURACIL (Spear Dermatology Products) 85ab7938-377f-497d-aab0-6a1223396372
            FLUOROURACIL (Spear Dermatology Products) a8857fe2-0bd1-4111-9eba-1eac25516e2e
            FLUOROURACIL (Taro Pharmaceutical Industries) 9a2c044d-83e4-42b4-9797-c344b8d3d152
            FLUOROURACIL (Taro Pharmaceuticals U.S.A.) 1b2f6145-b338-42ed-88a7-f4da65c59164
            FLUOROURACIL (Taro Pharmaceuticals U.S.A.) acca0036-f19c-459b-9dfc-9592f1cd588d
            ADRUCIL (Teva Parenteral Medicines) b90e0da7-f702-4f09-9488-74f2bb20e9ac
            ADRUCIL (Teva Parenteral Medicines) e0794add-67a7-4308-93e9-f889472716cc
FORMULA     C4H3FN2O2
EXACT_MASS  130.0179
MOL_WEIGHT  130.0772
CLASS       Antineoplastic
             DG01958  Nucleic acid derivative, antineoplastic
              DG01935  Fluoropyrimidine antineoplastic
             DG01935  Fluoropyrimidine antineoplastic
            Unclassified
             DG02018  Antimetabolite
              DG01958  Nucleic acid derivative, antineoplastic
               DG01935  Fluoropyrimidine antineoplastic
REMARK      Same as: C07649
            Therapeutic category: 4223
            ATC code: L01BC02
            Chemical group: DG00687
ACTIVITY    Antineoplastic, Antimetabolite
COMMENT     Fluorouracil exerts its anticancer effects through inhibition of thymidylate synthase (TYMS) and misincorporation of its metabolites into RNA and DNA in place of uracil or thymine.
TARGET      TYMS [HSA:7298] [KO:K00560]
  PATHWAY   hsa00240(7298)  Pyrimidine metabolism
            hsa00670(7298)  One carbon pool by folate
METABOLISM  Enzyme: DPYD [HSA:1806]
INTERACTION Genomic biomarker: DPYD [HSA:1806]
STR_MAP     map07041  Antineoplastics - antimetabolic agents
OTHER_MAP   map00983  Drug metabolism - other enzymes
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01B ANTIMETABOLITES
                L01BC Pyrimidine analogues
                 L01BC02 Fluorouracil
                  D00584  Fluorouracil (JP17/USP/INN)
            USP drug classification [BR:br08302]
             Dermatological Agents
              Fluorouracil
               D00584  Fluorouracil (JP17/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               422  Antimetabolites
                4223  Fluorouracils
                 D00584  Fluorouracil (JP17/USP/INN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Transferases
               thymidylate synthase
                Fluorouracil
                 D00584  Fluorouracil (JP17/USP/INN)
            Cytochrome P450 interactions [BR:br08309]
             CYP inhbitors
              CYP2C9
               Fluorouracil
                D00584  Fluorouracil (JP17/USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00584  Fluorouracil
            Antineoplastics [br08340.html]
             D00584
            Pharmacogenomic biomarkers in FDA drug labels [br08341.html]
             Polymorphisms and germline mutations
              D00584
DBLINKS     CAS: 51-21-8
            PubChem: 7847650
            ChEBI: 46345
            ChEMBL: CHEMBL185
            DrugBank: DB00544
            PDB-CCD: URF
            LigandBox: D00584
            NIKKAJI: J4.489J
ATOM        9
            1   C8y C    20.7957  -18.3013
            2   C8y C    19.5791  -19.0057
            3   N4x N    22.0068  -19.0057
            4   O5x O    20.7843  -16.8981
            5   C8x C    19.5791  -20.4030
            6   X   F    18.3622  -18.3013
            7   C8y C    22.0068  -20.4030
            8   N4x N    20.7957  -21.1017
            9   O5x O    23.2061  -21.1017
BOND        9
            1     1   2 1
            2     1   3 1
            3     1   4 2
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     5   8 1
            8     7   9 2
            9     7   8 1
///
